Learn More
Medchemexpress LLC Zilovertamab vedotin | 98.6% | 1 MG

Supplier: Medchemexpress LLC HYP999561MG
Zilovertamab vedotin is an antibody-drug conjugate for preclinical cancer research that combines a humanized anti-ROR1 monoclonal antibody with the cytotoxic payload monomethyl vedotin. It is supplied as a lyophilized powder for experimental use.
- targets receptor tyrosine kinase-like orphan receptor 1 (ROR1)
- contains monomethyl vedotin cytotoxic payload
- suitable for in vitro and in vivo research
- high reported purity (98.61%)
- documentation available: certificate of analysis and safety data sheet
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.